×
戻る Agenda
Session 5: Panel Discussion
Session Chair(s)
Rei Maeda
Consultant
Independent Consultant for Drug PV, Japan
Hiroyuki Murakami, PhD
Duputy Review Director, Office of New Drug I
Pharmaceuticals and Medical Devices Agency (PMDA), Japan